AngioDynamics, Inc. (ANGO)

Market Cap	487.39M
Revenue (ttm)	300.72M
Net Income (ttm)	-32.10M
Shares Out	41.20M
EPS (ttm)	-0.78
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	626,232
Open	11.48
Previous Close	11.41
Day's Range	11.43 - 11.88
52-Week Range	6.11 - 13.50
Beta	0.78
Analysts	Strong Buy
Price Target	19.33 (+63.4%)
Earnings Date	Oct 2, 2025

About ANGO

AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. It offers Auryon Atherectomy system that delivers an optimized wavelength and short pulse width to remove lesions while preserving vessel wall endothelium. The company’s thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device tha...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: May 27, 2004
• Employees: 675
• Stock Exchange: NASDAQ
• Ticker Symbol: ANGO
• Website: https://www.angiodynamics.com

Financial Performance

In 2025, AngioDynamics's revenue was $292.50 million, a decrease of -3.76% compared to the previous year's $303.91 million. Losses were -$33.99 million, -81.56% less than in 2024.

Analyst Summary

According to 3 analysts, the average rating for ANGO stock is "Strong Buy." The 12-month stock price target is $19.33, which is an increase of 63.40% from the latest price.

Price Target

$19.33

(63.40% upside)

Analyst Consensus: Strong Buy